Difference between revisions of "Basic Behavioral Neurology Clinical Concepts"

 
(4 intermediate revisions by 2 users not shown)
Line 1: Line 1:
'''Mild cognitive impairment definitions'''
+
==Mild cognitive impairment==
 +
'''Definition'''
  
 
- Alzheimer Disease Research Center (ADRC) criteria (Albert et al, 2011)
 
- Alzheimer Disease Research Center (ADRC) criteria (Albert et al, 2011)
Line 17: Line 18:
 
- Epidemiology (Petersen 2016)
 
- Epidemiology (Petersen 2016)
 
# 15-20% of patients over the age of 60 have MCI  
 
# 15-20% of patients over the age of 60 have MCI  
 +
# Not everybody with MCI will progress to develop dementia
 
# The annual rate in which MCI progresses to dementia varies between 8% and 15% per year  
 
# The annual rate in which MCI progresses to dementia varies between 8% and 15% per year  
  
Line 25: Line 27:
 
* Advanced activities of daily living: vocational skills, vocational knowledge, hobby-related mastery, music, art
 
* Advanced activities of daily living: vocational skills, vocational knowledge, hobby-related mastery, music, art
  
 
+
==Dementia==
'''Dementia definition''' (McKhann 2011)
+
'''Definition''' (McKhann 2011)
  
 
Cognitive or behavioral (neuropsychiatric) symptoms that:
 
Cognitive or behavioral (neuropsychiatric) symptoms that:
Line 45: Line 47:
 
Epidemiology: 70-80% of dementia is contributable to Alzheimer’s pathology, vascular disease, or some combination of the two; Lewy body disease contributes to 5%; the rest includes a large number of pathologies with lower prevalence (McKhann 2011)
 
Epidemiology: 70-80% of dementia is contributable to Alzheimer’s pathology, vascular disease, or some combination of the two; Lewy body disease contributes to 5%; the rest includes a large number of pathologies with lower prevalence (McKhann 2011)
  
 
+
===Basic Overview of Dementias===
'''Basic Overview of Dementias''' (McKhann 2011)
+
(McKhann 2011)
  
 
[[Alzheimer dementia]]
 
[[Alzheimer dementia]]
* presenting cognitive syndrome: amnestic, logopenic variant, posterior cortical atrophy
+
* presenting cognitive syndrome: amnestic, logopenic variant, posterior cortical atrophy, dysexecutive AD
 
* risk factors: age, vascular risk factors, TBI, low education, genetics
 
* risk factors: age, vascular risk factors, TBI, low education, genetics
* characteristic lesions: amyloid plaque (Abeta42), fibrillary tangles (Ptau)
+
* characteristic lesions: amyloid plaque (Abeta42), fibrillary tangles (P-tau)
  
  
Line 73: Line 75:
  
 
[[Dementia with Lewy bodies]]
 
[[Dementia with Lewy bodies]]
* presenting cognitive syndrome: hallucinations, fluctuation in cognition and level of alertness, Parkinsonism, visuospatial problems
+
* presenting cognitive syndrome: hallucinations, fluctuation in cognition and level of alertness, Parkinsonism, visuospatial problems, dream enactment (due to REM-sleep behavior disorder)
 
* risk factors: family history of PD, susceptibility genes (APOE4), low education, vascular risk factors, depression and anxiety. Protective: smoking, history of cancer
 
* risk factors: family history of PD, susceptibility genes (APOE4), low education, vascular risk factors, depression and anxiety. Protective: smoking, history of cancer
 
* characteristic lesions: alpha-synuclein predominantly in cortical area, high degree of coexistence of amyloid pathology
 
* characteristic lesions: alpha-synuclein predominantly in cortical area, high degree of coexistence of amyloid pathology
Line 79: Line 81:
  
 
[[Progressive supranuclear palsy (Steele-Richardson-Olszewski)]]
 
[[Progressive supranuclear palsy (Steele-Richardson-Olszewski)]]
* presenting cognitive syndrome: slow vertical saccade, gait instability, Parkinsonism
+
* presenting cognitive syndrome: slow vertical saccade, gait instability, Parkinsonism (poorly-responsive to levodopa)
 
* risk factors: not well understood
 
* risk factors: not well understood
 
* characteristic lesions: tufted astrocytes, tau and neurodegeneration in brainstem and basal ganglia
 
* characteristic lesions: tufted astrocytes, tau and neurodegeneration in brainstem and basal ganglia
Line 85: Line 87:
  
 
[[Corticobasal syndrome / corticobasal degeneration]]
 
[[Corticobasal syndrome / corticobasal degeneration]]
* presenting cognitive syndrome: asymmetrical apraxia, asymmetrical dystonia or myoclonus, and Parkinsonism
+
* presenting cognitive syndrome: asymmetrical apraxia, asymmetrical dystonia or myoclonus, and Parkinsonism, some patients exhibit alien-limb phenomenon
 
* risk factors: not well understood
 
* risk factors: not well understood
* characteristic lesions: achromatic ballooned neurons, 4R tau mostly, astrocytic plaques, parietal and temporal atrophy
+
* characteristic lesions: achromatic ballooned neurons, 4R tau mostly, astrocytic plaques, parietal and temporal (perisylvian) atrophy
  
  
 
== References ==
 
== References ==
Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 270–279 (2011) https://pubmed.ncbi.nlm.nih.gov/21514249/
+
Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 270–279 (2011) [https://pubmed.ncbi.nlm.nih.gov/21514249/ PubMed link]
  
McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 263–269 (2011). https://pubmed.ncbi.nlm.nih.gov/21514250/
+
McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 263–269 (2011). [https://pubmed.ncbi.nlm.nih.gov/21514250/ PubMed link]
  
Petersen, R. C. Mild Cognitive Impairment. Continuum 22, 404–18 (2016) https://pubmed.ncbi.nlm.nih.gov/27042901/
+
Petersen, R. C. Mild Cognitive Impairment. Continuum 22, 404–18 (2016) [https://pubmed.ncbi.nlm.nih.gov/27042901/ PubMed link]
  
Salardini, A. An Overview of Primary Dementias as Clinicopathological Entities. Semin. Neurol. 39, 153–166 (2019). https://pubmed.ncbi.nlm.nih.gov/30925609/
+
Salardini, A. An Overview of Primary Dementias as Clinicopathological Entities. Semin. Neurol. 39, 153–166 (2019). [https://pubmed.ncbi.nlm.nih.gov/30925609/ PubMed link]

Latest revision as of 15:51, 5 August 2022

Mild cognitive impairment

Definition

- Alzheimer Disease Research Center (ADRC) criteria (Albert et al, 2011)

  1. Concern regarding an intraindividual change in cognition
  2. Impairment in one or more cognitive domains
  3. Preservation of independence in functional abilities
  4. Not demented


- Petersen criteria (Petersen 2016)

  1. Memory complaints per subject and/or collateral source
  2. Intact activities of daily living
  3. Clinical dementia rating scale of 0.5
  4. Performance on a delayed memory test that is at least one standard deviation below the mean for the subject’s age


- Epidemiology (Petersen 2016)

  1. 15-20% of patients over the age of 60 have MCI
  2. Not everybody with MCI will progress to develop dementia
  3. The annual rate in which MCI progresses to dementia varies between 8% and 15% per year


Levels of Functioning (Salardini 2019)

  • Activities of daily living: dressing, bathing, toileting, continence, transferring, eating
  • Instrumental activities of daily living: shopping, preparing food, housework, laundry, use transportation, medication compliance, handling finances
  • Advanced activities of daily living: vocational skills, vocational knowledge, hobby-related mastery, music, art

Dementia

Definition (McKhann 2011)

Cognitive or behavioral (neuropsychiatric) symptoms that:

  1. Interfere with the ability to function at work or at usual activities; and
  2. Represent a decline from previous levels of functioning and performing; and
  3. Are not explained by delirium or major psychiatric disorder.
  4. Cognitive impairment is detected and diagnosed through a combination of
    1. History-taking from the patient and a knowledgeable informant and
    2. Objective cognitive assessment, either a “bedside” mental status examination or neuropsychological testing
  5. The cognitive or behavioral impairment involves a minimum of two of the following domains:
    1. Impaired ability to acquire and remember new information
    2. Impaired reasoning and handling of complex tasks, poor judgment
    3. Impaired visuospatial abilities
    4. Impaired language functions
    5. Changes in personality, behavior, or comportment


Epidemiology: 70-80% of dementia is contributable to Alzheimer’s pathology, vascular disease, or some combination of the two; Lewy body disease contributes to 5%; the rest includes a large number of pathologies with lower prevalence (McKhann 2011)

Basic Overview of Dementias

(McKhann 2011)

Alzheimer dementia

  • presenting cognitive syndrome: amnestic, logopenic variant, posterior cortical atrophy, dysexecutive AD
  • risk factors: age, vascular risk factors, TBI, low education, genetics
  • characteristic lesions: amyloid plaque (Abeta42), fibrillary tangles (P-tau)


Vascular dementia and subcortical ischemic vascular disease

  • presenting cognitive syndrome: large vessel is highly variable; small vessel presents with subcortical cognitive impairment
  • risk factors: age, vascular risk factors (HTN, DM, HLD, smoking, etc.), genetics
  • characteristic lesions: white matter hyperintensities, microhemorrhages, lacunes, enlarged perivascular spaces


Frontotemporal dementia


Parkinson's disease dementia

  • presenting cognitive syndrome: subcortical dementia
  • risk factors: TBI, family history of PD, environmental pesticides
  • characteristic lesions: alpha-synuclein predominantly in subcortical structures


Dementia with Lewy bodies

  • presenting cognitive syndrome: hallucinations, fluctuation in cognition and level of alertness, Parkinsonism, visuospatial problems, dream enactment (due to REM-sleep behavior disorder)
  • risk factors: family history of PD, susceptibility genes (APOE4), low education, vascular risk factors, depression and anxiety. Protective: smoking, history of cancer
  • characteristic lesions: alpha-synuclein predominantly in cortical area, high degree of coexistence of amyloid pathology


Progressive supranuclear palsy (Steele-Richardson-Olszewski)

  • presenting cognitive syndrome: slow vertical saccade, gait instability, Parkinsonism (poorly-responsive to levodopa)
  • risk factors: not well understood
  • characteristic lesions: tufted astrocytes, tau and neurodegeneration in brainstem and basal ganglia


Corticobasal syndrome / corticobasal degeneration

  • presenting cognitive syndrome: asymmetrical apraxia, asymmetrical dystonia or myoclonus, and Parkinsonism, some patients exhibit alien-limb phenomenon
  • risk factors: not well understood
  • characteristic lesions: achromatic ballooned neurons, 4R tau mostly, astrocytic plaques, parietal and temporal (perisylvian) atrophy


References

Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 270–279 (2011) PubMed link

McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 263–269 (2011). PubMed link

Petersen, R. C. Mild Cognitive Impairment. Continuum 22, 404–18 (2016) PubMed link

Salardini, A. An Overview of Primary Dementias as Clinicopathological Entities. Semin. Neurol. 39, 153–166 (2019). PubMed link